Support for a potential relevance of antibodies against SRRM3 and TSPYL5 proteins comes from the observed association between their levels and cognitive impairment, and between TSPYL5 and muscle pain, in piME/CFS patients. The gene discussed is SRRM3; the disease is Cognitive impairment.